MAKO Surgical Corp.|4Dec 17, 4:50 PM ET

MAKO Surgical Corp. 4

4 · MAKO Surgical Corp. · Filed Dec 17, 2013

Form 4

Period: 2013-12-17

Director

Transactions

Disposition to Issuer
Common Stock
2013-12-17$30.00/sh−7,775$233,250→ 0 total
Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$18.36/sh−17,317$317,940→ 0 total
Exercise: $11.64Exp: 2023-06-04→ Common Stock (17,317 underlying)
Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$19.73/sh−3,300$65,109→ 0 total
Exercise: $10.27Exp: 2020-08-23→ Common Stock (3,300 underlying)
Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$4.54/sh−3,338$15,155→ 0 total
Exercise: $25.46Exp: 2022-06-11→ Common Stock (3,338 underlying)
Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$2.93/sh−3,300$9,669→ 0 total
Exercise: $27.07Exp: 2021-06-16→ Common Stock (3,300 underlying)

Footnotes (2)

[F1]Pursuant to the Agreement and Plan of Merger ("Merger Agreement"), dated September 25, 2013, by and among the issuer, Stryker Corporation, and Lauderdale Merger Corporation, each share of the issuer's common stock was exchanged for a cash payment of $30.00.
[F2]Pursuant to the Merger Agreement, each outstanding stock option, whether vested or unvested, was canceled in exchange for a cash payment equal to the amount, if any, by which $30.00 exceeded the exercise price payable per share under each such stock option.

Documents

1 file